Cargando…

Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis

Background: Spasticity is a common sequela of stroke. The incidence of poststroke spasticity (PSS) has not been systematically reviewed in recent years, and some risk factors remain debated. This systematic review and meta-analysis was conducted to determine the prevalence and risk factors for PSS....

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Huangling, Chen, Jian, Guo, Yang, Tan, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855612/
https://www.ncbi.nlm.nih.gov/pubmed/33551975
http://dx.doi.org/10.3389/fneur.2020.616097
_version_ 1783646193746706432
author Zeng, Huangling
Chen, Jian
Guo, Yang
Tan, Sheng
author_facet Zeng, Huangling
Chen, Jian
Guo, Yang
Tan, Sheng
author_sort Zeng, Huangling
collection PubMed
description Background: Spasticity is a common sequela of stroke. The incidence of poststroke spasticity (PSS) has not been systematically reviewed in recent years, and some risk factors remain debated. This systematic review and meta-analysis was conducted to determine the prevalence and risk factors for PSS. Methods: We searched electronic databases (PubMed, Embase, Cochrane Library, CNKI, WANFANG and CBM) inception to May 12, 2020. Observational studies summarizing the incidence or risk factors for PSS were included. Only cohort studies were enrolled in meta-analysis. For risk factors examined in at least three different studies, we combined effects into odds ratios (OR) and 95% confidence intervals (CI). Results: One thousand four hundred sixty-seven studies were retrieved and 23 were involved in meta-analysis. The pooled prevalence of spasticity after stroke was 25.3% and that after the first-ever stroke was 26.7%. The incidence of spasticity after the first-ever stroke with paresis was 39.5%. The prevalence of disabling or severe spasticity (MAS ≥ 3) in stroke patients with paresis was 9.4% (95% CI 0.056–0.133), and severe spasticity was 10.3% (95% CI 0.058–0.149). Moderate to severe paresis (OR = 6.573, 95% CI 2.579–16.755, I(2) = 0.0%), hemorrhagic stroke (OR = 1.879, 95% CI 1.418–2.490, I(2) = 27.3%) and sensory disorder were risk factors for PSS. Conclusions: The incidence of PSS was significantly higher in stroke patients with paresis. Patients with moderate to severe paresis and sensory disorder should be closely followed up. The role of hemorrhagic stroke in predicting PSS remains to be further explored.
format Online
Article
Text
id pubmed-7855612
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78556122021-02-04 Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis Zeng, Huangling Chen, Jian Guo, Yang Tan, Sheng Front Neurol Neurology Background: Spasticity is a common sequela of stroke. The incidence of poststroke spasticity (PSS) has not been systematically reviewed in recent years, and some risk factors remain debated. This systematic review and meta-analysis was conducted to determine the prevalence and risk factors for PSS. Methods: We searched electronic databases (PubMed, Embase, Cochrane Library, CNKI, WANFANG and CBM) inception to May 12, 2020. Observational studies summarizing the incidence or risk factors for PSS were included. Only cohort studies were enrolled in meta-analysis. For risk factors examined in at least three different studies, we combined effects into odds ratios (OR) and 95% confidence intervals (CI). Results: One thousand four hundred sixty-seven studies were retrieved and 23 were involved in meta-analysis. The pooled prevalence of spasticity after stroke was 25.3% and that after the first-ever stroke was 26.7%. The incidence of spasticity after the first-ever stroke with paresis was 39.5%. The prevalence of disabling or severe spasticity (MAS ≥ 3) in stroke patients with paresis was 9.4% (95% CI 0.056–0.133), and severe spasticity was 10.3% (95% CI 0.058–0.149). Moderate to severe paresis (OR = 6.573, 95% CI 2.579–16.755, I(2) = 0.0%), hemorrhagic stroke (OR = 1.879, 95% CI 1.418–2.490, I(2) = 27.3%) and sensory disorder were risk factors for PSS. Conclusions: The incidence of PSS was significantly higher in stroke patients with paresis. Patients with moderate to severe paresis and sensory disorder should be closely followed up. The role of hemorrhagic stroke in predicting PSS remains to be further explored. Frontiers Media S.A. 2021-01-20 /pmc/articles/PMC7855612/ /pubmed/33551975 http://dx.doi.org/10.3389/fneur.2020.616097 Text en Copyright © 2021 Zeng, Chen, Guo and Tan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Zeng, Huangling
Chen, Jian
Guo, Yang
Tan, Sheng
Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis
title Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis
title_full Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis
title_fullStr Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis
title_full_unstemmed Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis
title_short Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis
title_sort prevalence and risk factors for spasticity after stroke: a systematic review and meta-analysis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855612/
https://www.ncbi.nlm.nih.gov/pubmed/33551975
http://dx.doi.org/10.3389/fneur.2020.616097
work_keys_str_mv AT zenghuangling prevalenceandriskfactorsforspasticityafterstrokeasystematicreviewandmetaanalysis
AT chenjian prevalenceandriskfactorsforspasticityafterstrokeasystematicreviewandmetaanalysis
AT guoyang prevalenceandriskfactorsforspasticityafterstrokeasystematicreviewandmetaanalysis
AT tansheng prevalenceandriskfactorsforspasticityafterstrokeasystematicreviewandmetaanalysis